450
Participants
Start Date
June 30, 2005
Primary Completion Date
April 30, 2007
Study Completion Date
April 30, 2007
Aripiprazole
Tablets, Oral, 15 mg fixed dose (week 1-5) flexible dose 10-30 mg (week 6-12), once daily, 12 weeks.
Aripiprazole
Tablets, Oral, Uptitration: 5 mg (week 1), 10 mg (week 2 and 3), 15 mg(week 4 and 5) flexible 10-30mg from week 6-12, once daily, 12 weeks.
Local Institution, Hall/Tirol
Local Institution, Vienna
Local Institution, Bruges
Local Institution, Brussels
Local Institution, Diest
Local Institution, Halle
Local Institution, Sint-Denijs-Westrem
Local Institution, Stokrooie
Local Institution, Havířov
Local Institution, Olomouc
Local Institution, Prague
Local Institution, Přerov
Local Institution, Aubagne
Local Institution, Bordeaux
Local Institution, Brumath
Local Institution, Château-Gontier
Local Institution, Clermont-Ferrand
Local Institution, Dijon
Local Institution, Dommartin-lès-Toul
Local Institution, Fains-Véel
Local Institution, Hénin-Beaumont
Local Institution, Le Pecq
Local Institution, Lyon
Local Institution, Poitiers
Local Institution, Reims
Local Institution, Roubaix
Local Institution, Toulon
Local Institution, Toulouse
Local Institution, Achim
Local Institution, Bochum
Local Institution, Cologne
Local Institution, Ellwangen
Local Institution, Hattingen
Local Institution, Neurnberg
Local Institution, Osnabrück
Local Institution, Ostfildern
Local Institution, Witten
Local Institution, Athens
Local Institution, Chania-Crete
Local Institution, Corfu
Local Institution, Leros
Local Institution, Thessaloniki
Local Institution, Tripoli
Local Institution, Baja
Local Institution, Eger
Local Institution, Esztergom
Local Institution, Kistarcsa
Local Institution, Pécs
Local Institution, Sopron
Local Institution, Sestri Ponente
Local Institution, Aosta
Local Institution, Bolzano
Local Institution, Foggia
Local Institution, L’Aquila
Local Institution, Milan
Local Institution, Roggiano Gravina (Cs)
Local Institution, Roma
Local Institution, Terrassa
Local Institution, Barcelona
Local Institution, Elche (Alicante)
Local Institution, Langreo-Asturias
Local Institution, Madrid
Local Institution, Murcia
Local Institution, Oviedo
Local Institution, Salamanca
Local Institution, Valencia
Local Institution, Zamora
Local Institution, Newport
Local Institution, South Wales
Local Institution, Hull
Local Institution, Dundee
Local Institution, Haywards Health
Collaborators (1)
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY